Related Experiment Video
Updated: May 2, 2026

Measuring Rates of Herbicide Metabolism in Dicot Weeds with an Excised Leaf Assay
Published on: September 7, 2015
Readily Adaptable Biosensor-Guided Platform Enables the Selection of Herbicide-Metabolizing CYP2B6 Variants
1The Robert H. Smith Institute of Plant Sciences and Genetics in Agriculture, The Hebrew University of Jerusalem, Rehovot 7610000, Israel.
We developed a new microbial system to engineer enzymes that modify small molecules. This platform uses evolvable biosensors to link enzyme activity to cell growth, accelerating biocatalyst development.
Area of Science:
- Biotechnology
- Synthetic Biology
- Enzyme Engineering
Background:
- Directed evolution of enzymes is hindered by the lack of scalable functional assays.
- Linking biocatalysis to microbial phenotypes typically requires complex, custom system development.
- Genetically encoded biosensors offer a modular approach to link enzyme activity to selectable phenotypes.
Purpose of the Study:
- To develop an integrated platform for biosensor evolution and enzyme screening within a unified microbial framework.
- To adapt a yeast two-hybrid system for coexpression and screening of cytochrome P450 enzymes (CYPs).
- To demonstrate the platform's utility by enhancing CYP2B6-mediated metabolism of the herbicide alachlor.
Main Methods:
- Utilized a yeast two-hybrid platform coupled with fluorescence-activated cell sorting.
- Employed PYRABACTIN RESISTANCE 1-like receptors and type 2C protein phosphatases as an evolvable biosensor module.
- Performed four rounds of biosensor-guided evolution targeting CYP2B6 expression and catalytic efficiency.
Main Results:
- Successfully adapted the yeast two-hybrid system for CYP screening.
- Isolated biosensor variants capable of discriminating between alachlor and its metabolite.
- Achieved significant improvements in CYP2B6 expression and catalytic efficiency through directed evolution.
Conclusions:
- The developed platform integrates evolvable biosensors and modular strain design for accelerated biocatalyst development.
- This system provides a powerful tool for engineering small-molecule-modifying enzymes, particularly CYPs.
- The approach facilitates the creation of custom biocatalysts by linking enzyme function to selectable microbial traits.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Microbial Biosensors

